Pharming Launches Joenja (Leniolisib) in Japan for APDS Patients Aged 4 and Older, Marking First Global Launch for Children 4 To 11
Benzinga Newsdesk 2 months ago
News
Launch marks first commercial availability of Joenja® (leniolisib) for children aged 4 to 11 worldwideOrphanPacific, Inc. serves as Marketing Authorization holder and is responsible for supply and distribution in Japan
- Launch marks first commercial availability of Joenja® (leniolisib) for children aged 4 to 11 worldwide
- OrphanPacific, Inc. serves as Marketing Authorization holder and is responsible for supply and distribution in Japan